Explore the Agenda

8:15 am Check In & Coffee

8:55 am Chair’s Opening Remarks

Associate Manager, R&pD Operations, Regeneron Pharmaceuticals

Elevating Leadership & Workforce Resilience to Enable Sustainable Scientific Productivity

9:00 am Panel: Earning Your Seat at the Table – Elevating Leadership Impact in R&D Operations

Senior Director & Head of Strategy & Research Operations, Bristol Myers Squibb
Director - Site Operations, Sanofi
Manager, Lab Operations, Pfizer
Director - Laboratory Operations, Vivodyne
  • Developing the leadership skills and confidence needed to operate as a strategic voice within science-driven organizations
  • Aligning closely with scientific priorities to reposition ops from a support function to a critical business partner
  • Demonstrating tangible value and influence to accelerate career progression and secure a seat at the leadership table

9:30 am Addressing Skills Gaps & Knowledge Loss to Sustain Operational Excellence with Leaner Teams

Associate Director, Global Offices & Workplace Experience, ACADIA Pharmaceuticals Inc.
  • Reducing disruption and rework caused by attrition and retirements by systematically capturing critical operational knowledge, minimizing dependency on individuals and protecting continuity of lab and site performance
  • Improving productivity and time-to-competence for new hires by standardizing training, onboarding, and competency frameworks, enabling lean teams to reach consistent performance faster with lower supervisory burden
  • Lowering operational and compliance risk by ensuring essential skills and decision-making capability are distributed, auditable, and resilient to workforce changes rather than embedded in tribal knowledge

10:00 am Morning Break & Networking

Track A

Track A: Running the Site

Overcoming long-term site sustainability, regulatory pressure, ESG mandates, and capital decision-making when investment dollars are scarce.

11:00 am Discover: Prioritizing Capital Investments Using Risk-Based Frameworks to Protect Critical Infrastructure

Director - Global Compound Management, Takeda Pharmaceutical
  • Maximizing return on limited capital budgets by directing investment toward the highest-risk infrastructure assets, avoiding low-impact spend while preventing failures that drive downtime, emergency repairs, and lost research output
  • Reducing unplanned outages and lifecycle cost creep by using risk-based prioritisation to address ageing, high-criticality systems before they become operational or compliance liabilities
  • Enabling faster, more defensible capital decisions by applying transparent, data-driven frameworks that align engineering, finance, and leadership around where investment delivers the greatest protection and long-term value

11:20 am Discover: The Adventure Continues – A Glimpse Into the Future of Lab Performance & the Value it Can Unlock for Your Organization

Founder & Chief Executive Officer, BioPhy
  • Purpose-built apps on one shared foundation deliver value individually while compounding – each module you switch on makes the next more valuable
  • ”Start small and grow” is real: begin with a spreadsheet upload and mature into full-service asset management without re-platforming or retraining
  • The platform keeps extending – new modules for scientific services, CapEx planning, and task management ship on the same foundation, turning lab operations into a lasting strategic advantage

11:40 am Discover: Redesigning Facilities Outsourcing Models to Restore Accountability, Speed Response Times, & Reduce Hidden Risk

Senior Program Director, Commercial, Fujifilm Corp.
  • Reducing costly delays and rework by clarifying ownership, escalation paths, and decision rights across multi-vendor outsourcing models, eliminating offs that slow response and increase downtime
  • Improving service responsiveness without increasing spending by restructuring vendor governance, performance metrics, and contract scope to focus on outcomes that directly support research continuity
  • Mitigating hidden operational and compliance risk by strengthening oversight of third-party providers, ensuring consistent execution, documentation, and accountability across sites and service partners

12:00 pm Develop: Shared Q&A

12:20 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

Track B

Track B: Running the Lab

Advancing operational reality, showing how labs can prepare for automation and AI without overreach or compliance risk.

11:00 am Discover: Pinpointing Where Automation Truly Delivers Value Towards Operational Impact

Lab Operations lead, Empress Therapeutics
  • Prioritize high impact use cases with real ROI by identifying automation opportunities grounded in data readiness, process stability, and integration feasibility – avoiding costly pilots that fail to scale or deliver measurable benefit
  • Drive meaningful workload reduction without added complexity by targeting repetitive, high-volume tasks with clear process ownership, ensuring automation simplifies operations rather than introducing new layers of oversight
  • Strengthen risk control while enabling smarter decisions by embedding human in the loop models that enhance consistency, auditability, and compliance without compromising accountability in regulated environments

11:20 am Discover: Leveraging Lifecycle Data to Optimize Instrument Strategy & Reduce Costs

Senior Associate Scientist, Analytical Operations, Gilead Sciences
  • Tracking instrument utilization and downtime to identify inefficiencies and drive smarter purchasing decisions
  • Informing decommissioning and new site buildouts with real usage data to avoid overinvestment and improve planning
  • Delivering significant cost savings through a scalable internal lifecycle management solution

11:40 am Discover: Shifting from Reactive Firefighting to Proactive Control to Improve Reliability, Predictability, & Confidence

Maintenance & Reliability Lead, Takeda Pharmaceutical
  • Reducing unplanned downtime and emergency spend by identifying repeat failure patterns and replacing reactive responses with structured, forward-looking operational controls
  • Improving forecast accuracy and delivery reliability by implementing leading indicators that enable teams to plan maintenance, staffing, and asset usage before disruptions occur
  • Restoring stakeholder confidence across R&D, operations, and leadership by creating predictable, repeatable operating models that support consistent performance despite external and internal pressure

12:00 pm Develop: Shared Q&A

12:20 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

12:50 pm Lunch

Track A

Strengthening operational resilience through risk management, predictive maintenance, and critical decision making.

1:50 pm Discover: Managing Facilities Risk Across In-House, CDMO, & Leased Manufacturing Environments

Senior Manager - Laboratory & Facilities Services, Arbor Biotechnologies, Inc.
  • Identify the most common hidden failure points, from utilities access and HVAC control to validation handovers and outage communication
  • Compare CAPEX ownership vs leasing risk to determine when owning infrastructure delivers greater resilience and regulatory certainty
  • Produce a Facilities Risk Ownership Map linking asset control, vendor dependency, escalation authority, and compliance exposure

2:10 pm Discover: Predictive Maintenance in Regulated Manufacturing, Deciding Where it is Safe, Valuable, or Dangerous

Site Head of Global Facilities, Engineering & Technology, Boehringer Ingelheim
  • Examine where preventive maintenance still dominates GMP environments and why extending intervals often fails
  • Map process, utilities, and equipment signals (SCADA, BMS, CMMS, historians) to identify realistic candidates for predictive approaches
  • Produce a Predictive Maintenance Suitability Matrix defining:
    • Where predictive methods add value
    • Where they should be avoided
    • Where hybrid models are appropriate

2:30 pm Develop: Shared Q&A

2:45 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

Track B

Enhancing laboratory performance through cost transparency, operational alignment, and reliability-centered maintenance.

1:50 pm Discover: Integrating Procurement, Facilities, & Lab Operations to Drive Cost Transparency & Operational Alignment

Manager of Lab Operations, Seattle Children’s Hospital
  • Reducing total operating cost and budget leakage by aligning procurement, facilities, and lab operations around shared visibility into assets, contracts, and demand, eliminating duplicated spend and unmanaged scope creep
  • Improving decision quality and speed by breaking down functional silos and creating a single, aligned view of cost, risk, and operational impact, enabling faster trade-offs when budgets and priorities are constrained
  • Increasing accountability and predictability across the value chain by coordinating sourcing, service delivery, and operational planning so costs, service levels, and performance expectations are clearly owned and measurable

2:10 pm Discover: Converting GMP Asset Criticality into Failure-Proof Maintenance & Reliability Strategy

Senior Director - Quality Control, Gilead Sciences
  • Apply manufacturing-grade asset criticality frameworks to categorize GMP, utility, and support assets based on downtime cost, compliance impact, and failure consequence
  • Translate criticality rankings into maintenance execution decisions, including PM frequency, condition-based strategies, spares policy, and engineering focus
  • Produce an Asset-to-Maintenance Execution Map that directly links asset criticality to maintenance workload, staffing priorities, and reliability risk

2:30 pm Develop: Shared Q&A

2:45 pm Action: Roundtable Session

Collaborate to identify practical starting points, potential barriers, and strategies for making necessary change.

Interactive Peer-Led Discussion Facilitated by the Chair

3:00 pm Afternoon Break

From Siloed Decisions to Shared Operational Direction

3:30 pm Future-Proofing Research Facilities: How UCSF Is Reinventing Support Models to Sustain Biomedical Innovation in Uncertain Times

Program Manager, Facilities Research Support Services, University of California, San Francisco
  • Reimagining service delivery at scale: How a new Facilities Services Coverage Model eliminates re-charges, streamlines access, and removes friction for researchers, enabling faster, more predictable support
  • Driving resilience through digital innovation: Leveraging APIs and remote temperature monitoring to safeguard critical research assets and maintain continuity despite hiring constraints and resource pressures
  • Modernizing operations with AI and communication: Harnessing enterprise ChatGPT and a new asset management approach, while strengthening crisis communication to ensure transparency, alignment, and trust across stakeholders

4:00 pm The LAFM Exchange

Where the industry sets the agenda – no presentations, no sales pitches, just conversations.

The conversations will now shift from the stage to the audience and wider community. A QR code will be on the screen, and you will allow submit the biggest challenge that you’re currently facing- and remember, a problem shared is a problem halved, so please share the biggest obstacle you’re facing.

We will collate all the challenges and bring them into 6 broad themes. These will then be randomly allocated to separate roundtables where we will dig into the challenge through 3 vital questions:

  • What is the why behind the why for this challenge?
  • What solutions have we thrown at this challenge and why or why not have they been successful?
  • What is the one high-value action that can be done to eradicate this challenge?

Facilitated by the Chair

4:30 pm Chair’s Closing Remarks

Associate Manager, R&pD Operations, Regeneron Pharmaceuticals

4:40 pm End of Conference